These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38608835)

  • 1. Do platelets protect the heart against ischemia/reperfusion injury or exacerbate cardiac ischemia/reperfusion injury? The role of PDGF, VEGF, and PAF.
    Voronkov NS; Maslov LN; Vyshlov EV; Mukhomedzyanov AV; Ryabov VV; Derkachev IA; Kan A; Gusakova SV; Gombozhapova AE; Panteleev OO
    Life Sci; 2024 Jun; 347():122617. PubMed ID: 38608835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation.
    Penna C; Alloatti G; Cappello S; Gattullo D; Berta G; Mognetti B; Losano G; Pagliaro P
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2512-20. PubMed ID: 15637120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of β-adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β-adrenergic receptor agonists and antagonists protect the heart?
    Maslov LN; Naryzhnaya NV; Voronkov NS; Kurbatov BK; Derkachev IA; Ryabov VV; Vyshlov EV; Kolpakov VV; Tomilova EA; Sapozhenkova EV; Singh N; Fu F; Pei J
    Fundam Clin Pharmacol; 2024 Aug; 38(4):658-673. PubMed ID: 38423796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin 1-7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart-The signaling mechanism.
    Derkachev IA; Popov SV; Maslov LN; Mukhomedzyanov AV; Naryzhnaya NV; Gorbunov AS; Kan A; Krylatov AV; Podoksenov YK; Stepanov IV; Gusakova SV; Fu F; Pei JM
    Fundam Clin Pharmacol; 2024 Jun; 38(3):489-501. PubMed ID: 38311344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target.
    Ziegler M; Wang X; Peter K
    Cardiovasc Res; 2019 Jun; 115(7):1178-1188. PubMed ID: 30906948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
    Loucks EB; Godin DV; Walley KR; McManus BM; Rahimian R; Granville DJ; Hong JM; Aktary FM; Qayumi AK
    Can J Cardiol; 2003 Mar; 19(3):267-74. PubMed ID: 12677282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor: the good and the bad in the ischemic/reperfused heart.
    Penna C; Bassino E; Alloatti G
    Exp Biol Med (Maywood); 2011 Apr; 236(4):390-401. PubMed ID: 21378031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Natriuretic Peptides in the Regulation of Cardiac Tolerance to Ischemia/Reperfusion and Postinfarction Heart Remodeling.
    Krylatov AV; Tsibulnikov SY; Mukhomedzyanov AV; Boshchenko AA; Goldberg VE; Jaggi AS; Erben RG; Maslov LN
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):131-148. PubMed ID: 32840121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-Derived MicroRNAs Regulate Cardiac Remodeling After Myocardial Ischemia.
    Schütte JP; Manke MC; Hemmen K; Münzer P; Schörg BF; Ramos GC; Pogoda M; Dicenta V; Hoffmann SHL; Pinnecker J; Kollotzek F; Zdanyte M; Mueller KAL; Singh Y; Mack AF; Pichler B; Lang F; Nieswandt B; Gawaz M; Heinze KG; Casadei N; Borst O
    Circ Res; 2023 Mar; 132(7):e96-e113. PubMed ID: 36891903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury.
    Loucks EB; Symersky P; Qayumi AK
    J Invest Surg; 1997; 10(6):321-38. PubMed ID: 9654389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor.
    Penna C; Mognetti B; Tullio F; Gattullo D; Mancardi D; Moro F; Pagliaro P; Alloatti G
    Acta Physiol (Oxf); 2009 Nov; 197(3):175-85. PubMed ID: 19432589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats.
    Yang S; Abbott GW; Gao WD; Liu J; Luo C; Hu Z
    J Appl Physiol (1985); 2017 May; 122(5):1095-1105. PubMed ID: 28153944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury.
    Penna C; Brancaccio M; Tullio F; Rubinetto C; Perrelli MG; Angotti C; Pagliaro P; Tarone G
    Basic Res Cardiol; 2014 Jul; 109(4):418. PubMed ID: 24859929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
    Obana M; Miyamoto K; Murasawa S; Iwakura T; Hayama A; Yamashita T; Shiragaki M; Kumagai S; Miyawaki A; Takewaki K; Matsumiya G; Maeda M; Yoshiyama M; Nakayama H; Fujio Y
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H569-77. PubMed ID: 22707562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury.
    Li GH; Luo B; Lv YX; Zheng F; Wang L; Wei MX; Li XY; Zhang L; Wang JN; Chen SY; Tang JM; He X
    J Transl Med; 2016 May; 14(1):116. PubMed ID: 27146579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of EphrinA2 receptors in postconditioning induced cardioprotection in rats.
    Kaur K; Singh N; Dhawan RK
    Eur J Pharmacol; 2020 Sep; 883():173231. PubMed ID: 32589885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.
    Luo T; Chen B; Zhao Z; He N; Zeng Z; Wu B; Fukushima Y; Dai M; Huang Q; Xu D; Bin J; Kitakaze M; Liao Y
    Basic Res Cardiol; 2013 May; 108(3):342. PubMed ID: 23467745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical translation of myocardial conditioning.
    Bøtker HE; Lassen TR; Jespersen NR
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1225-H1252. PubMed ID: 29498531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.